Corvus Pharmaceuticals Inc buy Mizuho
Start price
20.05.25
/
50%
€3.27
Target price
20.05.26
€9.79
Performance (%)
218.38%
End price
21.05.26
€10.40
Summary
This prediction ended on 21.05.26 with a price of €10.40. The BUY prediction by Mizuho for Corvus Pharmaceuticals Inc saw massive gains of 218.38%. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | 9.051% | 9.051% | 223.707% |
| iShares Core DAX® | -1,36 % | -2,16 % | 2,08 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % | 32,60 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % | 58,27 % |
| iShares S&P 500 | -1,66 % | -0,70 % | 22,96 % |
Comments by Mizuho for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Mizuho from $12.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von Mizuho gewählte maximale Laufzeit wurde überschritten